样式: 排序: IF: - GO 导出 标记为已读
-
Colposcopy performance in the new primary HPV screening in Australia: How to determine colposcopy competency? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-03-01 Jeffrey H.J. Tan, Deborah Neesham, Rebecca A. Szabo, Natalia Khomko, Desiree Yap, C. David H. Wrede
AimsTo assess colposcopic performance and determine indicators for competency within the new Australian primary human papillomavirus (HPV) cervical screening program.Materials and methodsA retrospective observational study of 4542 women seen at The Royal Women's Hospital Colposcopy Clinic in Melbourne, from 1 December 2017 to 31 July 2020 after a higher‐risk cervical screening test (CST) result.ResultsHistological
-
Improving accuracy of outcome prediction for infants born extremely preterm using a digital tool: Translating ‘NIC‐PREDICT’ into clinical practice, the first steps Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-03-01 Rosemarie A. Boland, Jeanie L.Y. Cheong, Michael J. Stewart, Stefan C. Kane, Lex W. Doyle
BackgroundMany clinicians overestimate mortality and disability rates in infants born extremely preterm. We developed a digital tool (‘NIC‐PREDICT’) that predicts infant mortality and survival with and without major disability in infants born 23–27 weeks' gestation.AimsTo determine if clinicians could use NIC‐PREDICT accurately, and if their perceptions of infant outcomes improved after its release
-
Efficacy and feasibility of the RADA16 self‐assembling peptide, PuraStat® for haemostasis in laparoscopic gynaecological surgery: A pilot study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-03-01 Philip Hall
Bleeding after laparoscopic gynaecological surgery remains a potential complication. We assessed RADA16 (PuraStat®), a topical self‐assembling peptide haemostatic agent, in a pilot study of 46 women undergoing laparoscopic gynaecological surgery. The primary outcome was intraoperative haemostatic efficacy for resection site bleeding. Haemostasis was achieved in all intraoperative bleeding situations
-
‘I was able to make a better decision about my health.’ Wāhine experiences of colposcopy at a marae‐based health clinic: A qualitative study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-03-01 Judy Ormandy, Simon Phillips, Maringikura Campbell, Bernie Haenga‐Melvin, Luana Phillips‐Govind, Sara Filoche
BackgroundEquitable access to colposcopy services is required if we are to realise the benefit of the introduction of human papilloma virus (HPV) screening in Aotearoa New Zealand. We piloted a community colposcopy clinic, co‐located at an urban marae health clinic.AimTo describe the experiences of wāhine (women) attending the marae‐based colposcopy clinic.MethodsAn in‐depth reflexive thematic analysis
-
A survey of cost, access and outcomes for cannabinoid‐based medicinal product use by Australians with endometriosis Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-28 Andrew Proudfoot, Sarah Duffy, Justin Sinclair, Jason Abbott, Mike Armour
People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self‐reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a ‘cannabis clinic’ doctor, incurring an initial consultation cost of $100–$200+ (10.2% Medicare bulk‐billed)
-
Conventional in vitro fertilisation rather than intracytoplasmic sperm injection when only one oocyte is retrieved: Time to overcome irrational fears Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-28 Valerio Pisaturo, Marco Reschini, Cristina Guarneri, Elena Sanzani, Alessio Paffoni, Edgardo Somigliana
BackgroundThe use of intracytoplasmic sperm injection (ICSI) currently extends beyond male factor infertility, notably replacing conventional in vitro fertilisation (IVF) in scenarios like limited oocyte availability, where it is used as a precaution against complete fertilisation failure. While existing studies on the use of conventional IVF in such situations provide some reassurance, the available
-
Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two‐centre study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-21 Christine A. Wade, Naomi Atkinson, Natasha E. Holmes, Lisa Hui
ObjectiveThe aim of this study was to evaluate the indications for maternal TORCH (Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV)) serology, with a focus on the yield in isolated fetal growth restriction (FGR).Materials and MethodsA retrospective review of antenatal TORCH testing between January 2014 and December 2018 was carried out at two hospitals in Melbourne
-
A step closer to parenthood with non-obstructive azoospermia: Unveiling the impact of microdissection testicular sperm extraction in Australia's largest single-centre study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-17 Hossam Elzeiny, Franca Agresta, John Stevens, David K. Gardner
Non-obstructive azoospermia (NOA) diagnosis poses challenges for couples seeking parenthood. Microdissection testicular sperm extraction (MD-TESE) excels in retrieving testicular sperm cells for NOA cases. However, limited live birth data in Australian NOA patients hinders accurate counselling.
-
Perfusion magnetic resonance imaging in Asherman syndrome Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-16 Rebecca Deans, Daniel Moses, Toos Anthony Sach, Thierry Vancaillie, Bill Ledger, Jason A. Abbott
Microvascular scarring compromises the functionality of the endometrium, and vascular flow at the junctional zone (JZ) may be the key to understanding poor reproductive outcomes in women with Asherman syndrome (AS).
-
Perinatal outcomes after regional analgesia during labour Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-13 Janna Lawson, Lahiru Amaratunge, Melody Goh, Roshan J. Selvaratnam
Regional analgesia is a common and effective form of in-labour analgesia. However, there are concerns whether it is associated with adverse maternal and neonatal outcomes.
-
ANZJOG in 2024 Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-04 Scott W. White
Welcome to the 64th volume of the Australian and New Zealand Journal of Obstetrics and Gynaecology. We are now well into a new year which brings much work to progress for our Journal in 2024. It is my hope that during this year we will continue to grow ANZJOG as a leading source of clinically relevant scientific literature, providing guidance to those in clinical roles and driving the work of those
-
Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-01 Niveditha Rajadevan, Ariane Flinkier, Hugo Saunders, Yeh Chen Lee, Clare Scott, Pearly Khaw, Prue Allan, Claire Davies, John Andrews, Michelle Wilson, Janine M Lombard, Michelle Harrison, Heshani Nesfield, Anna DeFazio, Tarek Meniawy, Kylie L Gorringe
Mucinous ovarian carcinoma (MOC) is a rare ovarian cancer with limited evidence to support clinical care.
-
Ultrasound-guided Lipiodol® hysterosalpingography: A prospective study on pregnancy and complication rates Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-02-01 Glen Lo, Dana Hince, Neil Johnson, Paul L. Hofman, Jasmin Sekhon, Emmeline Lee
Fluoroscopic hysterosalpingography (HSG) with Lipiodol® is safe and has a therapeutic effect on fertility: transient in endometriosis-related infertility and sustained in unexplained infertility. Ultrasound is replacing fluoroscopy as the preferred imaging modality for HSG due to comfort and radiation safety (no ionising radiation). The safety of ultrasound-guided Lipiodol® HSG is uncertain.
-
Diverse presentations of Cushing's syndrome during pregnancy – A case series Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-29 Natasha Stoinis, Katherine Creeper, Jessica Phillips, Dorothy Graham, Ee Mun Lim
Cushing's syndrome (CS) encompasses various causes of hypercortisolism including adrenocorticotropic hormone (ACTH) secreting pituitary adenoma with or without bilateral adrenal hyperplasia, an adrenal adenoma or carcinoma, ectopic ACTH or corticotrophin-releasing hormone (CRH) secretion by a neoplasm or exogenous corticosteroid therapy. The diagnosis of CS in pregnancy presents a challenge due to
-
A cross-sectional study exploring the characteristics of female survivors of sexual violence living with HIV/AIDS in the eastern region of Democratic Republic of Congo Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-25 Olivier Nyakio, Fabrice Kibukila, Denis Mukwege, Joyeux Bwani, Albert Tambwe, Priyadarshini Bhattacharjee, Soham Bandyopadhyay, Aymar Akilimali, Prosper Kakudji, Jean Baptiste Kakoma
Sexual violence remains a persistent and devastating issue in eastern Democratic Republic of Congo (DRC).
-
An audit of the maternal medicine clinic: Cancer and pregnancy Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-24 Mia Harrison, Mark P. Umstad, Wanda Cui, Iniyaval Thevathasan, Sarah A.L. Price
To explore the incidence and complexity of women presenting for maternity care who require concurrent cancer care, and to report the birth outcomes of these women.
-
Infertility in the Pacific: A crucial component of the sexual and reproductive health and rights agenda Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-23 Elke MitchellSenior Research Fellow, Linda Rae Bennett
Across Pacific Island countries, women and men are disproportionately affected by several risk factors for infertility, including sexually transmissible infections, complications from unsafe abortions, postpartum sepsis, obesity, diabetes, tobacco smoking and excessive alcohol consumption. Despite this, little is known about community awareness of infertility, behavioural risk factors, the lived experiences
-
Severe acute maternal morbidity reporting in Australia: Why is it so hard? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-12 Joanne Frost, Edward Weaver, Leonie Callaway
Adverse outcomes associated with pregnancy, including severe acute maternal morbidity (SAMM) and mortality, are internationally regarded as important indicators of quality of maternity services. Varied definitions and processes are barriers for SAMM recording, reporting and review. Identifying and documenting these cases of SAMM is a critical first step. Case reviews allow exploration of factors contributing
-
Sexual and reproductive health services in New Zealand primary care settings: A mixed-methods survey Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-11 Orna McGinn, Michelle Wise
New Zealand's recently released Women's Health Strategy aims to provide accessible, equitable care which prioritises prevention, early intervention and areas of unmet need. An example of such care is the management of common sexual and reproductive health (SRH) issues by appropriately trained primary care practitioners in the community.
-
Pregnancy outcomes post-kidney transplantation across 23 years Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-08 Jessica Han, Ciara Anne McCormick, Anna Krelle, Paul Champion de Crespigny, Julia Unterscheider
Pregnancy in kidney transplant recipients has become increasingly common. However, pregnancy carries higher risks to these patients compared to the general population.
-
Continuity obstetric care demonstrates greater vaginal birth after caesarean success Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2024-01-05 Georgina Facchetti, Zhen Teo, Meenu Sharma, Aaron Budden
Australia's caesarean rate is higher than Organisation for Economic Co-operation and Development (OECD) average, and is rising. Vaginal birth after caesarean (VBAC) is safe for selected women. Midwifery continuity of care (CoC) is associated with higher rates of vaginal birth compared to other models; however, impacts on VBAC attempts and success are unknown.
-
Variation in clinical practice guideline recommendations for medication use in pregnancy in Australia: A systematic review Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-17 Hayley T. Cron, Peter Simm, Joanne M. Said, Jeanie L. Y. Cheong, Noel Cranswick, Yanhong Jessika Hu
Medication use in pregnancy is common; however, it is unknown if clinical practice guideline (CPG) prescribing recommendations referred to in Australia at the state, national and international level are consistent.
-
Final thoughts from ANZJOG in 2023 Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-18 Scott W. White
Welcome to the final issue of ANZJOG Volume 63. Another year rapidly draws to a close and most of us find ourselves busy in the lead up to the end of year festivities and, hopefully, a rest. As healthcare workers in a field which lacks respect for office hours and holidays, many ANZJOG readers will again leave their own families at times of celebration to provide care for the families of others. I
-
Main Program Abstracts Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-14
MONDAY 30 OCTOBER 2023PLENARY—Conflict and Justice
-
Three Minute Thesis Abstracts Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-14
Does Day 1 Haemoglobin Drop Correlate with Visual Estimated Blood Loss at Caesarean Section? M FAHY1,2, C KO1, M MAYNARD1 and K KALIAN1,3 1Eastern Health, 2Monash Health, 3Monash University Introduction: There is an increasing focus on improving the accuracy of estimated blood loss (EBL), with the introduction of weighed quantitative blood loss (QBL) in many maternity units. QBL at caesarean section
-
Static Poster Abstracts Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-14
Effects of Psychosocial Work Factors on Preterm Birth: Systematic Review and Meta-analysis H ADANE, R ILES, J BOYLE and A COLLIE Monash University Introduction: Preterm birth is a primary global health issue that results in high rates of infant mortality and long-term health complications. We sought to explore the association between psychosocial work factors and preterm birth. Method: We searched
-
E-Poster Abstracts Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-14
How Good are We at Doing Delayed Cord Clamping in Premature Babies? Compliance with Guidelines and Improvement Following Targeted Strategies L ABRAHAM, E WILSON and M BECKMANN Mater Mothers Hospital Background: The practice of delayed cord clamping (DCC) for approximately 60 seconds after birth is of proven benefit to the neonate. Preterm babies, in particular, benefit from improved intravascular volume
-
Author Index Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-14
ABBEY, S. 31 ABRAHAM, L. 39 ACTON, J. 15 ADAMS, R. 53, 54 ADANE, H. 29 ADENIYI, J. 45 ADES, A. 53, 72 ADHINUGRAHA, K. 8 AGARWAL, A. 39 AGRESTA, F. 8 AHADZADA, Z. 40 AHMADZAI, M. 40 AITKEN, G. 29 ALI MOHAN, G.K. 71 ALIM, M. 40, 41 ALLANSON, E. 3, 6, 7, 11, 15, 31, 42, 71 ALLEN, M. 14 ANANTHARACHAGAN, A. 48 ANDERSON, A. 16 ANDERSON, K. 4, 8 ANDREATIDIS, B. 41 ANDREWS, C. 15 ANG, C. 33 ANWAR, R. 63 ARACHCHILAGE
-
Testicular fine-needle aspiration in infertile men with absolute non-obstructive azoospermia: A single-centre cohort study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-12-11 Jawad Sakas, Orit Radin, Noa Abrahami, Osnat Altshuler, Johnny S. Younis
The methodology of surgically extracted sperm cells in fertility treatments remains debated, mainly due to the lack of data evaluating its predictive value on treatment outcomes.
-
Fertility and infertility uses of menstrual apps from the perspectives of healthcare providers and patients Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-30 Bryndl Hohmann-Marriott, Tiffany Williams, Jane Girling
Menstrual cycle tracking apps are increasingly used by those trying to conceive as well as those diagnosed and treated for infertility. However, the small amount of existing research about the use of these apps does not include the perspectives of healthcare providers.
-
How well are we collecting umbilical cord lactate and gas samples? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-23 Trang Minh Bui, Malcolm Battin, Lynn Sadler
The aim of this study is to measure staff compliance with the local umbilical cord lactate (UCL) sampling guideline and investigate the quality of paired UCG samples at a tertiary maternity unit.
-
The use of intraperitoneal chemotherapy for advanced ovarian cancer – The experience of a tertiary referral centre Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-22 Leon Foster, Christina Girgis, Adrienne Kirby, Paul Harnett, Alison Brand
Platinum-based chemotherapy is the backbone of the medical management of ovarian cancer. The dose, route and timing of treatment are ongoing areas of debate. Intraperitoneal (IP) chemotherapy is an alternative delivery method treatment to the conventional intravenous (IV) route for patients with epithelial ovarian cancer, with efficacy supported by Level 1 evidence.
-
Incidence and management of premature rupture of membranes in Victoria, Australia: A retrospective cohort study of 636 590 births between 2009 and 2017 Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-20 Natalie Jardine Cameron, Dagmar Wertaschnigg, Mary-Ann Davey, Renée Janne Burger, Ben Willem Mol, Andrea Mary Woolner
Premature rupture of membranes (PROM) is a complication affecting 7–12% of pregnancies in which fetal chorioamniotic membranes rupture before labour begins. Preterm PROM (PPROM) (ie <37 weeks gestation) precedes one-third of preterm births, exposing the fetus to increased morbidity from placental abruption, respiratory distress syndrome and sepsis.
-
Fostering interdisciplinary colorectal and gynaecology surgery networks during training is crucial to maximise expertise and innovate patient care Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-20 Mina Sarofim, Mikhail Sarofim
The importance of interdisciplinary collaboration between specialties has gained significant recognition in recent years, and rightly so with notable benefits to skills acquisition and patient outcomes. Due to the scope of overlapping procedures and clinical scenarios, developing trustable networks between colorectal and gynaecology surgeons must be encouraged as a focus of trainee education. This
-
Identifying women with a disability in Australian maternity services: Time for a change Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-14 Charlie A. Benzie, Michelle S. Newton, Helen L. McLachlan, Della A. Forster
It is estimated that over 1 billion people worldwide have a disability. In Australia, 9% of women of childbearing age have a disability, but data on disability status for women accessing maternity services are not routinely collected and data collection processes are inconsistent. Maternal disability may affect perinatal outcomes, but to understand what factors might be amenable to interventions to
-
Low-risk gestational trophoblastic neoplasia – 20 years experience of a state registry Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-14 Carmel McInerney, Orla McNally, Thomas James Cade, Antonia Jones, Deborah Neesham, Yael Naaman
Gestational trophoblastic disease (GTD) is an uncommon but highly treatable condition. There is limited local evidence to guide therapy.
-
The impact of body mass index on labour management and mode of delivery: A retrospective matched cohort study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-14 Kan-feng Zheng, Madeleine N. Jones, Ben W. Mol, Daniel L. Rolnik
This study aims to examine the association between body mass index (BMI) and mode of delivery, progression of labour, and intrapartum interventions.
-
Non-invasive tests for endometriosis are here; how reliable are they, and what should we do with the results? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-07 Simon M. Scheck, Claire Henry, Nick Bedford, Jason Abbott, Michael Wynn-Williams, Anusch Yazdani, Simon McDowell
A reliable non-invasive biomarker for endometriosis is highly likely in the coming years. In the lead-up to this, clinicians need to be aware of commercially available tests as they become accessible, be aware of the level of evidence to support them and be prepared to counsel and manage patients who present with the results of such tests. One such test gaining popularity in Europe was developed using
-
Short communication: Where is women's cardiovascular health taught in Australian and New Zealand medical schools? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-11-06 Aphakorn Hasdarngkul, Annemarie Hennessy, Shivany Vignarajan
Cardiovascular disease is a major cause of mortality in women and is the leading cause of pregnancy-related mortality in Australia. This study aims to discover the extent of teaching regarding women's cardiovascular health in Australian and New Zealand medical schools. All 22 medical schools in Australia and New Zealand were approached for participation in completing this survey. Seven medical schools
-
Acceptability of using the Raising Awareness Tool for Endometriosis (RATE) in general practice: a mixed methods pilot study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-31 Jacqueline Frayne, Talila Milroy, Charlotte Rook, Magdalena Simonis, Alan Lam
The Raising Awareness Tool for Endometriosis (RATE) was developed to facilitate discussions with health providers regarding endometriosis-associated symptoms. We aim to evaluate the acceptability of the RATE by general practitioners (GP), including determining the prevalence of symptoms of women presenting to general practice and immediate management of symptoms.
-
Causes of stillbirth in ethnically diverse women in a Perth metropolitan hospital: A retrospective study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-31 Kriti Sharma, Saiuj Bhat, Sangeeta Malla Bhat
Most published reports analysing the differences in causation of stillbirth between different ethnic groups focus on stillbirth risk factors, with a paucity of data comparing actual causes of stillbirth.
-
Retrospective review of endometriosis surgery at Te Whatu Ora – Capital and Coast Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-31 Emily S. J. Paterson, Simon Scheck, Simon McDowell, Nicholas Bedford, Jane E. Girling, Claire E. Henry
Endometriosis is an under-researched disease, with Aotearoa-specific data severely lacking. Current estimates of parameters such as rates of endometriosis diagnosis, indication for surgery and sites of disease are based on international data. There is currently no published data on endometriosis surgeries in Aotearoa New Zealand.
-
Treatment of rectosigmoid endometriosis by laparoscopic reverse submucosal dissection (LRSD): The Sydney partial thickness discoid excision technique Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-31 Jessica Robertson, Jason Abbott, Sophie Corbett-Burns, Mujahid Bukhari, Shevy Perera, Assem Kalantan, Mikhail Sarofim, Rebecca Chou, Greg Cario, David Rosen, Sarah Choi, Michael Wynn-Williams, George Condous, Danny Chou
Laparoscopic reverse submucosal dissection (LRSD) is a standardised surgical technique for removal of rectosigmoid endometriosis which optimises the anatomical dissection plane for excision of endometriotic nodules.
-
Sonographer-guided frozen embryo transfer vs ultrasound-assisted frozen embryo transfer – A randomised controlled study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-26 Juliette Koch, Rebecca Redden, Gillian Homan, Bronwen Roberts, Leanne Pacella-Ince
The use of ultrasound to guide placement of the embryo during in vitro fertilisation (IVF) is important, but there are times where a good image cannot be obtained. Having a trained sonographer perform the ultrasound may therefore improve the success of embryo transfer.
-
Education in ANZJOG and under RANZCOG: Primary purpose or secondary intention? Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-25 Katrina Calvert, Ian Symonds
In June 1963 Sir Arthur Bell, then President of the Royal College of Obstetricians and Gynaecologists, gave the 10th Arthur Wilson Memorial Oration, at the National Gallery in Melbourne. In his oration Sir Arthur quoted the 1929 memorandum of association, written at the inception of the College and outlining its purpose: ‘The encouragement of the study and the improvement of the practice of obstetrics
-
The pregnant traveller: An overview of general travel advice Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-23 Melinda Fernando, Michelle L. Giles, Sushena Krishnaswamy, Stephen Cole
Travel during pregnancy is common, but is associated with a number of risks and potential problems. There are many pregnancy-specific and destination-specific issues to be considered along with issues related to method of transport. Travel experiences should be made as safe as possible through evidence-based counselling via pregnancy healthcare providers prior to travel. This travelling in pregnancy
-
Vaccination recommendations for pregnant people travelling overseas Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-23 Adrian Alexander, Sushena Krishnaswamy, Stephen Cole, Michelle L. Giles
With international travel on the rise following pandemic restrictions, the number of pregnant travellers is likely to proportionally increase. Recent published data suggest most pregnant travellers seek pre-travel advice from their maternity and primary care providers. With these data, it is important to provide maternity and primary care providers with guidelines and resources to help aid safe, informed
-
The pregnant traveller: An overview of common preventable infections Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-23 Wen Jie Isaac Lee, Michelle L. Giles, Stephen Cole, Sushena Krishnaswamy
Pregnant travellers are often unaware of the various infections that can be acquired during travel and that pregnant people may be at increased risk of severe disease compared to their non-pregnant counterparts. Pregnant people often seek pre-travel counselling from their obstetrician or primary care physicians, who may not be well versed in travel medicine. This paper aims to provide information for
-
How well do we truly understand clitoral anatomy? An Irish maternity hospital's perspective Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-15 Maeve White, Hollie Byrne, Zara Molphy, Karen Flood
The clitoris has long been ignored in medical literature and teaching, with the first paper describing its anatomy only published in 1993. It is essential that those working in women's health understand the anatomy of this important female sexual organ.
-
Parents’ descriptions of labouring with an antepartum fetal death: Findings from the Birthing in Grief study Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-13 Jane Warland, Danielle Pollock, Ashleigh Collier, Dell Horey, Frances Boyle
Evidence to guide intrapartum care when an unborn baby has died is limited.
-
Vaginal atrophy and genital pain in women on depot medroxyprogesterone acetate contraceptive injection Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-10 Nicky Perkins
Depot medroxyprogesterone acetate causes a hypo-estrogenic state in over half of users although clinical vaginal atrophy causing superficial dyspareunia is thought rarely to occur. This is a case series of ten women using depot medroxyprogesterone acetate who presented with superficial dyspareunia and clinical vaginal atrophy. The women were treated with vaginal estriol cream and their contraception
-
Placental cord drainage vs delayed cord clamping at elective caesarean section: A randomised controlled trial Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-29 Michael James Fahy, Christy Ko, Matilda Maynard, Kiran N. Kalian
Placental cord drainage (PCD) after vaginal birth accelerates placental delivery by 2.85 minutes, but reduces blood loss by only 77 mL.
-
Identifying the barriers faced by obstetricians and registrars in screening or enquiry of intimate partner violence in pregnancy: A systematic review of the primary evidence Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-02 Corrine Lu, Ekavi Georgousopoulou, Surriya Baloch, Dianne Walton-Sonda, Kelsey Hegarty, Farah Sethna, Nick A.T. Brown
Intimate partner violence (IPV) disproportionally affects women compared to men. The impact of IPV is amplified during pregnancy. Screening or enquiry in the antenatal outpatient setting regarding IPV has been fraught with barriers that prevent recognition and the ability to intervene.
-
Are we over-testing for vitamin D? A 12-month review at the Royal Women's hospital, Melbourne. Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-01 Melissa Qiao Wei Ang,Ying Gu
-
Increased demand for abortion information and advice during the COVID-19 pandemic. Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-10-01 Yan Cheng,Jessica Botfield,Clare Boerma,Jane Estoesta
-
Intrahepatic cholestasis of pregnancy: Contemporary management Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-29 Scott W. White
Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disorder of pregnancy, occurring in up to 4% of women and varying in frequency according to ethnicity, fetal plurality, mode of conception, and concurrent hepatitis C virus infection.1 It is characterised by itch and elevated serum bile acids. The association with adverse perinatal outcomes, particularly stillbirth, has previously
-
Evidence for the role of multidisciplinary team care in people with pelvic pain and endometriosis: A systematic review Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-27 Qing Yi Fang, Nikki Campbell, Samantha S. Mooney, Sarah J. Holdsworth-Carson, Kate Tyson
Endometriosis is a chronic, inflammatory condition characterised by the presence of endometrial-like tissue outside the uterine cavity. Given the multi-system nature of the disease and the potential for significant negative impact on quality of life, there has been a long-standing recognition of the need for multidisciplinary care for people with endometriosis. However, there is paucity to the data
-
Receiving the baton Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-23 Scott W. White
Welcome to issue 63 (5) of ANZJOG. It is my great pleasure to present this issue, my first as Editor-in-Chief of the Journal. I would like my first words to be of thanks to my immediate predecessor, Professor Caroline de Costa. It is a humbling and daunting experience to take the reins from a luminary of Australian obstetrics and gynaecology. Professor de Costa was Editor-in-Chief for over seven years
-
Increasing incidence of endometrial cancer in Aotearoa New Zealand: Health professionals' perspective Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-22 Linda Williams, Claire Henry, Bryony Simcock, Sara Filoche
The incidence of endometrial cancer is globally increasing. Aotearoa New Zealand is no exception with a 59% increase in cases over that last ten years.
-
When you see nothing at all: Outcomes following a negative laparoscopy. A systematic review Aust. N. Z. J. Obstet. Gynaecol. (IF 1.7) Pub Date : 2023-09-22 Lucy A. Steele, Samantha S. Mooney, Ebony S. Gilbee, Sonia R. Grover
Persistent pelvic pain (PPP) is a complex and often debilitating condition. While widely accepted to be multifactorial in nature, the precise aetiology of PPP remains elusive. In many cases, women who undergo laparoscopy for PPP will have no visible pathology identified (a ‘negative’ laparoscopy). Currently, there are no consensus guidelines which outline the recommended management following a negative